A Unified Index to Predict the Success Probability of Myopia Control
Myopia, Progressive
About this trial
This is an interventional treatment trial for Myopia, Progressive
Eligibility Criteria
Inclusion Criteria: Older than 7 years of age or younger than 12 years of age, Spherical equivalent (SE) greater -1.00 D and less than-5.00 D, Corneal astigmatism ≤ 1.50 D, best-corrected visual acuity better than 20/25, No binocular vision dysfunction, No obvious angle kappa, No history of an OK-lens or MFCL wear or any other myopia control treatments such as atropine, application of atropine for cycloplegia during the past 30 days, No contact lens contraindications, No related ocular or systemic disease. Exclusion Criteria: Younger than 7 years of age or older than 12 years of age, Spherical equivalent (SE) less than -1.00 D or greater than-5.00 D, Corneal astigmatism > 1.50 D, Best-corrected visual acuity less than 20/25, Binocular vision dysfunction, Obvious angle kappa, History of an OK-lens or MFCL wear or any other myopia control treatments such as atropine, application of atropine for cycloplegia during the past 30 days, Contact lens contraindications, Related ocular or systemic disease.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
orthokeratology lens
multifocal soft contact lens
single vision spectacle
The subjects will wear an orthokeratology lens with 3-zone reverse geometry design. The subjects are instructed to wear the lenses for at least eight hours every night and are removed during daytime hours.
The subjects will wear a multifocal soft contact lens during daytime hours and remove the lens at night
The subjects will wear single vision spectacle lens as control.